Working in the clinical trial space teaches you a lot about resilience, there is a sense of duty to get things done, and this intensifies, especially
if you are patient-facing. The whole industry is raising its investment in patient-centric capabilities as it hunts for the perfect contingency plan. Chris Wells at Illingsworth Research Group explains how to navigate the new norm of clinical trials, highlighting that investment is now being led by what patients will value.